<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ikeda K</submitter><funding>JSPS Program for Advancing Strategic International Networks</funding><funding>Uehara Memorial Foundation</funding><funding>JSPS Research Fellowships for Young Scientists</funding><funding>Pancreas Research Foundation of Japan</funding><funding>Japan Society for the Promotion of Science</funding><pagination>179-183</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5668656</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>2</volume><pubmed_abstract>In diabetes mellitus, pituitary adenylate cyclase-activating polypeptide (PACAP) has insulinotropic and glucose-lowering properties. We previously demonstrated that transgenic mice overexpressing PACAP in pancreatic β-cells (PACAP-Tg) show attenuated pancreatic islet hyperplasia and hyperinsulinemia in type 2 diabetic models. To explore the underlying mechanisms, here we crossed PACAP-Tg mice with lethal yellow agouti (KKAy) diabetic mice, and performed gene chip analysis of laser capture microdissected pancreatic islets from four F1 offspring genotypes (wild-type, PACAP-Tg, KKAy, and PACAP-Tg:KKAy). We identified 1371 probes with >16-fold differences between at least one pair of genotypes, and classified the probes into five clusters with characteristic expression patterns. Gene ontology enrichment analysis showed that genes involved in the terms ribosome and intracellular organelles such as ribonucleoprotein complex, mitochondrion, and chromosome organization were significantly enriched in clusters characterized by up-regulated genes in PACAP-Tg:KKAy mice compared with KKAy mice. These results may provide insight into the mechanisms of diabetes that accompany islet hyperplasia and amelioration by PACAP.</pubmed_abstract><journal>Biochemistry and biophysics reports</journal><pubmed_title>Comparative gene expression profiles in pancreatic islets associated with agouti yellow mutation and PACAP overexpression in mice.</pubmed_title><pmcid>PMC5668656</pmcid><funding_grant_id>S2603</funding_grant_id><pubmed_authors>Tomimoto S</pubmed_authors><pubmed_authors>Tsuchiya S</pubmed_authors><pubmed_authors>Hamagami KI</pubmed_authors><pubmed_authors>Nakazawa T</pubmed_authors><pubmed_authors>Ichikawa A</pubmed_authors><pubmed_authors>Nagayasu K</pubmed_authors><pubmed_authors>Sugimoto Y</pubmed_authors><pubmed_authors>Ikeda K</pubmed_authors><pubmed_authors>Shintani N</pubmed_authors><pubmed_authors>Baba A</pubmed_authors><pubmed_authors>Kasai A</pubmed_authors><pubmed_authors>Hayata-Takano A</pubmed_authors><pubmed_authors>Hashimoto H</pubmed_authors></additional><is_claimable>false</is_claimable><name>Comparative gene expression profiles in pancreatic islets associated with agouti yellow mutation and PACAP overexpression in mice.</name><description>In diabetes mellitus, pituitary adenylate cyclase-activating polypeptide (PACAP) has insulinotropic and glucose-lowering properties. We previously demonstrated that transgenic mice overexpressing PACAP in pancreatic β-cells (PACAP-Tg) show attenuated pancreatic islet hyperplasia and hyperinsulinemia in type 2 diabetic models. To explore the underlying mechanisms, here we crossed PACAP-Tg mice with lethal yellow agouti (KKAy) diabetic mice, and performed gene chip analysis of laser capture microdissected pancreatic islets from four F1 offspring genotypes (wild-type, PACAP-Tg, KKAy, and PACAP-Tg:KKAy). We identified 1371 probes with >16-fold differences between at least one pair of genotypes, and classified the probes into five clusters with characteristic expression patterns. Gene ontology enrichment analysis showed that genes involved in the terms ribosome and intracellular organelles such as ribonucleoprotein complex, mitochondrion, and chromosome organization were significantly enriched in clusters characterized by up-regulated genes in PACAP-Tg:KKAy mice compared with KKAy mice. These results may provide insight into the mechanisms of diabetes that accompany islet hyperplasia and amelioration by PACAP.</description><dates><release>2015-01-01T00:00:00Z</release><publication>2015 Jul</publication><modification>2024-11-10T00:58:22.673Z</modification><creation>2019-03-27T03:00:48Z</creation></dates><accession>S-EPMC5668656</accession><cross_references><pubmed>29124161</pubmed><doi>10.1016/j.bbrep.2015.06.006</doi></cross_references></HashMap>